Trial Profile
Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables and Cerebrovascular Reactivity in Patients With Recent Stroke or TIA.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Apr 2014
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Stroke; Transient ischaemic attacks
- Focus Adverse reactions
- Sponsors Orion
- 01 Apr 2014 New trial record
- 24 Nov 2009
- 28 Oct 2008